Targeting Glutamine Metabolism in Hepatic Stellate Cells for
2026-06-24
The referenced study reveals that modulation of glutamine metabolism in hepatic stellate cells (HSCs)—particularly by inhibiting glutamate dehydrogenase (GDH) activity and restoring mitochondrial sirtuin 4 (SIRT4) expression—can significantly attenuate liver fibrosis. These findings provide mechanistic insight into fibrosis progression and highlight new avenues for therapeutic intervention targeting HSC metabolism.
T-5224 (C-Fos/AP-1 Inhibitor): Advanced Workflows in Inflamm
2026-06-23
T-5224 empowers researchers to dissect and modulate AP-1-driven inflammatory pathways with high selectivity and reproducibility, facilitating translational applications from cell culture to complex in vivo disease models. Learn how to harness its unique mechanism and troubleshoot key protocol steps for robust outcomes in arthritis and neuroinflammation research.
Artesunate: Applied Oncology Workflows and Experimental Mast
2026-06-23
Artesunate, a high-purity artemisinin derivative, is redefining in vitro cancer research with potent, reproducible induction of ferroptosis and AKT/mTOR pathway inhibition. Learn how optimized protocols and troubleshooting strategies maximize its impact in small cell lung carcinoma and esophageal squamous cell carcinoma models.
CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti
2026-06-22
CUDC-907 is a dual PI3K and HDAC inhibitor intended for controlled in vitro research on cancer signaling, apoptosis, and cell cycle regulation. It enables simultaneous modulation of key pathways in validated cell models, but is not suitable for diagnostic or clinical use. Researchers should follow precise storage, handling, and workflow protocols to ensure reproducible results.
L-Phenylephrine (SKU C3021): Reliable α1A Agonist for Resear
2026-06-22
This article provides evidence-based guidance on leveraging L-Phenylephrine (SKU C3021) for robust α1A-adrenergic receptor signaling assays, addressing challenges in reproducibility, specificity, and protocol optimization. It walks bench scientists through real-world scenarios—spanning cell viability to cardiovascular modeling—demonstrating how APExBIO’s high-purity L-Phenylephrine supports reliable, interpretable outcomes across experimental contexts.
DFO (9H-1,8-Diazafluoren-9-one): Reliable Fluorescence for L
2026-06-21
This article provides a scenario-driven, evidence-based guide to using DFO (9H-1,8-Diazafluoren-9-one, SKU C6997) in cell viability and detection workflows. It highlights real-world solutions for assay reproducibility, sensitivity, and reagent handling, with direct links to product data and best practices. Biomedical researchers and lab technicians will benefit from actionable insights grounded in literature and validated protocols.
Chloroquine Diphosphate: Mechanisms and Research Benchmarks
2026-06-20
Chloroquine diphosphate is a validated TLR7/TLR9 inhibitor and autophagy modulator. It arrests the cell cycle at G1 and enhances cancer cell sensitivity to chemotherapeutics. Its benchmark in vitro IC50 is 15–40 µM, and it is widely used for autophagy assays and cancer research.
EZ Cap™ Firefly Luciferase mRNA: Optimizing Reporter Assays
2026-06-19
EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure combines robust mRNA stability and high translational efficiency to deliver sensitive, low-background bioluminescent reporting. Its advanced design is ideal for precise gene regulation studies, quantitative translation assays, and in vivo imaging workflows.
Discovery of PAS: A PRC2 Subunit Essential for Subtelomeric
2026-06-19
This study identifies PAS, a previously uncharacterized accessory subunit of the Polycomb repressive complex 2 (PRC2), as a critical determinant for subtelomeric H3K27 methylation and gene repression in Neurospora crassa. The findings advance understanding of chromatin regulation mechanisms and provide new avenues for dissecting PRC2 function in fungal and broader eukaryotic systems.
Molidustat (BAY85-3934): Applied Workflows for Renal Anemia
2026-06-18
Harness the precision of Molidustat (BAY85-3934) for advanced erythropoietin stimulation and robust hypoxia-inducible factor stabilization. This guide translates cutting-edge research into practical workflow enhancements, troubleshooting advice, and comparative insights for chronic kidney disease anemia models.
AG-490 (Tyrphostin B42): Applied JAK2/STAT6 Inhibition in HC
2026-06-18
AG-490 (Tyrphostin B42) uniquely empowers researchers to dissect the JAK2/STAT6 axis in hepatocellular carcinoma, especially in the context of exosome-mediated immune modulation. This guide translates recent discoveries into actionable protocols and troubleshooting strategies for optimal pathway inhibition and immunopathological state suppression.
Aminopeptidase Inhibitor Phebestin: Advances in Antimalarial
2026-06-17
The referenced study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a potent antiplasmodial agent active against both sensitive and resistant strains of Plasmodium falciparum. This discovery highlights new therapeutic avenues targeting parasite-specific proteolytic pathways, with implications for overcoming antimalarial drug resistance.
CHIR-99021 (CT99021): Reliable GSK-3 Inhibition in Stem Cell
2026-06-17
Explore how CHIR-99021 (CT99021), SKU A3011, addresses key challenges in cell viability and differentiation assays. This scenario-driven guide highlights evidence-based strategies for reproducible signaling modulation, optimal protocol design, and confident product selection with APExBIO’s reagent.
GANT61: GLI Inhibitor Strategies for Tumor Immune Evasion St
2026-06-16
GANT61 empowers cancer researchers to dissect Hedgehog-GLI pathway roles in immune evasion and therapy resistance with unparalleled specificity. This guide delivers workflow enhancements, troubleshooting tactics, and key experimental parameters to maximize GLI inhibition in advanced tumor models.
3-hydroxybutyrate (BHBA) in Neuroprotection and Metabolic Re
2026-06-16
Harnessing 3-hydroxybutyrate (BHBA) enables researchers to model in vitro ketosis and dissect the interplay between cellular metabolism and epigenetic regulation. This guide walks through experimental workflows, key innovations in neuroprotection, and actionable troubleshooting tips for optimized use of BHBA in advanced metabolic disease research.
458 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page